The incidence of relapses or second episodes of varicella attributable to corticosteroid therapy was further studied by Crisalli and Terragna (1956) . These authors gave cortisone to 22 patients at varying time intervals (10-60 days) after varicella. Typical signs of varicella reappeared in 11 cases, but always after the sudden discontinuance of steroid therapy. These observations were considered as 'due to cortisone'. However, the significance of the steroid withdrawal was not discussed.
The literature of the decade following the reports of Josserand et al. and Shee and Fehrsen contained articles with diametrically contrasting data on the question of the effect of steroid therapy on varicella. While sound judgements are difficult to make under such circumstances, the bibliographical review does give an estimate of the magnitude of the problem and, in addition, provides data from which one may decide whether the severity of varicella in a steroidtreated patient is dependent upon (a) the nature of the initial disorder for which corticosteroids were administered, (b) the duration and dosage of steroid therapy, and (c) the therapeutic manipulations of the clinician in managing the situation (abrupt discontinuation, increase or decrease of steroid therapy) during both the incubation period and the acute phase of varicella.
A marked difference in the mortality figures in the reports appearing before and after 1958 was noted (Table 1) (Aceto, Blizzard, and Migeon, 1962) . Of the 21 cases reported before 1958, 16 terminated fatally. The remaining 5 represent too small a number to permit meaningful comparisons with the 231 cases reported in articles published after 1958 that recovered uneventfully. It appeared, however, that there was no significant difference in the dose and duration of therapy in these two groups. To permit a x2 analysis of the data (not possible otherwise with numbers of cases as small as these) the distribution was limited to two items: (1) therapy maintained or increased, and (2) therapy decreased or stopped. Considering only these two points, the difference in management before and after 1958 was not found to be statistically significant (x2 = 1 X 12, had been discontinued during the 12 months preceding varicella, and in 4 of them the therapy had been stopped during the incubation period. The course of these patients during the exanthematous disease was followed very closely with special attention to possible signs or symptoms of adrenal insufficiency. All of these children ran an uneventful course.
Despite the absence of obvious complications, the possibility was considered that the over-all severity of varicella might be different in the three groups of patients described, i.e. children who had not received steroid therapy for at least one year before varicella, children who were on maintenance therapy with steroids, and children in whom therapy was stopped within the 12 months preceding varicella. The magnitude of the febrile response and the duration of fever were thought worth investigating in view of the well-known antipyretic effect of the adrenocortical hormones. Table 6 . The analysis of variance technique, used to evaluate the differences observed, was that of a single variable of classification, with unequal-sized subgroup samples (Dixon and Massey, 1957) . The over-all severity of varicella and the extent and duration of the exanthema were not found to be affected by steroid therapy (F = 0-81). Fever was also not affected by steroids in the dosage range employed (F = 0 * 20). It was also noted that fever in these children was not accompanied by a consistent reduction in the severity of asthma, as had been noted and reported previously (Falliers et al., 1961) .
The initial inspection of the data gave the impression that older children, on steroid therapy, appeared more susceptible to varicella. In fact, the relation between age and steroid therapy was not found to be statistically significant (F = 0 58). The three oldest children had a history of having had varicella in the past. This historical information could not be confirmed with absolute certainty, but the possibility exists that in these three the varicella observed by us represented a second attack in a steroid-treated child.
In all cases except one steroid therapy was maintained or slightly increased during varicella. The sole exception was the first case in this series seen by the authors. At this time we were influenced here by the grave prognosis indicated in the early published reports, and a discontinuance of therapy on the third day of the illness was considered advisable. A more 'physiological' thinking has prevailed since, and, summarizing an experience with 21 cases, we have found that varicella pursued its ordinary course in children in whom the daily dose of prednisone was maintained at the low levels usually sufficient for reasonable control of asthma.
Discussion
Despite the great interest in the nature of viral agents and the diseases caused by them during the past few decades, the precise mechanisms of resistance to viral infection are unclear. One is still unable to assess the relative importance in viral immunity of humoral factors such as antibody, cellular factors, e.g. the interferons, and hypersensitivity of the delayed type (Friedman, Baron, Buckler, and Steinmuller, 1962; Wagner, 1963; Hale, 1961) . Superimposing the effects of corticosteroids upon this already complex problem further beclouds the issue. There is a voluminous literature on the effects of corticosteroids on resistance to infection (Kass and Finland, 1958) . In attempting to evaluate the experimental data that bear upon this question, it is well to consider the following points.
(1) The species of animal with which one deals is of great significance. The effects of cortisol on resistance to infection in the mouse, rat, and rabbit, whose major adrenal cortical hormones are not the 17-OH corticoids (Bush, 1951) , may be quite different from the effects of these same steroids in the guineapig, monkey, and man. Experiments in the former group of animals, receiving 17-OH corticosteroids, which show heightened susceptibility to infection, must be interpreted in the light of the possibility that these 'foreign corticosteroids' have a more profound effect on their metabolism in general, and specifically on their resistance to infection. In species such as man, whose major corticosteroids are the 17-OH derivatives, the effect of addition of these hormones may be a quantitative one only (Long, 1960) .
(2) The timing of the administration of the corticosteroids in relation to the giving of the antigenic stimulus (either natural or artificial) influences the effect of the steroid on antibody production. Given after antibody production is already underway, corticosteroids have little, if any, effect and are similar in this regard to the effect of x-irradiation and cytotoxic drugs (Berglund, 1956) .
(3) As with other agents that affect antibody production, the factor of dosage is of great importance. The corticosteroid dosage used in many of the animal experiments was, when related to body weight, many times in excess of what ordinarily would be used in man.
Recent brief reports have indicated that the viral exanthematous diseases, rubeola and rubella, usually run an uneventful course when occurring in children treated with corticosteroids (Falliers et al., 1961; Gerbeaux et al., 1963) . The opposite has been the case with varicella, where an increase in mortality has been alleged to occur and be a direct result of the steroid hormones. It seems clear that the corticosteroid-varicella combination may be lethal in those disorders in which an underlying defect in the immune mechanism is known to exist, e.g. malignancy (Miller, 1962) . However, when the immune mechanism is not compromised by the primary disease, a corticosteroid-varicella hazard is unproven. In reviewing the deaths reported in this latter group, one is impressed by the lack of specific details, especially regarding the dose of corticosteroid at the time of death (Haggerty and Eley, 1956; Eley, 1961) . It has been accurately noted that 'at the present time we are conditioned to associate the administration of corticosteroids or ACTH with an increased susceptibility of man to infectious agents' (Raffel, 1961) . Since it has been recommended that corticosteroids be stopped in the face of varicella (Eley, 1961) , it is quite possible that this course of action was followed in a number of the fatal cases. Death, then, may have resulted from adrenal insufficiency (Aceto et al., 1962) , precipitated by the stress of varicella, in a patient dependent upon exogenous corticosteroids. Mortality more likely occurred as a result of not using steroids rather than using them. Some of the catastrophic deaths occurring in steroid-treated asthmatics may likewise have resulted from a similar reluctance to reinstitute or increase steroid therapy in stressful situations, which, of course, would include severe asthma.
Summary
Two hundred and seventy-four cases of varicella occurring in children who were receivingcorticosteroids have been reported from all over the world between the years 1953 and 1963. Mortality was higher in the period before 1958 than thereafter. The reasons for this have been discussed. A significantly higher mortality was found in cases treated with steroids for leukaemia and other haematological disorders, as well as for rheumatic and connective-tissue diseases, than in illnesses in which the immune mechanism is not thought to be compromised.
Of the 59 cases of varicella seen at C.A.R.I.H. during a six-year period, 21 were on corticosteroid therapy. No fatalities and no serious complications attributable to the adrenal cortical hormones were noted; indeed, steroid therapy did not influence the degree of duration of pyrexia, nor the extent or severity of the exanthematous eruption, as compared to a group of controls. When a child receiving steroids for a chronic disorder is exposed to or becomes ill with varicella, therapy at physiological levels equivalent to 25-50 mg./day ofcortisone should be continued. Abrupt withdrawal of corticosteroids in the face of any potentially stressful disease, such as varicella, is unphysiological and hazardous. 
